Immunogenicity of the CYD tetravalent dengue vaccine using an accelerated schedule: randomised phase II study in US adults

by Judith Kirstein, William Douglas, Manoj Thakur, Mark Boaz, Thomas Papa, Anna Skipetrova, Eric Plennevaux
Published 2018-09-01

Safety Overview of a Recombinant Live-Attenuated Tetravalent Dengue Vaccine: Pooled Analysis of Data from 18 Clinical Trials.

by Sophia Gailhardou, Anna Skipetrova, Gustavo H Dayan, John Jezorwski, Melanie Saville, Diane Van der Vliet, T Anh Wartel
Published 2016-07-01